<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>BMC Medicine via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'BMC Medicine' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=BMC+Medicine&t=BMC+Medicine&s=Search&f=source]]></link>
        <lastBuildDate>Mon, 06 Feb 2012 09:02:23 +0100</lastBuildDate>
        <item>
            <title>Outbreaks of virulent diarrhoeagenic Escherichia coli - are we in control?</title>
            <link>http://www.medworm.com/index.php?rid=5654490&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F10%2F11</link>
            <description>Improvements in management strategies to control Shiga toxin-producing E. coli (STEC) outbreaks are discussed by Dirk Werber et al, who advocate early detection via careful surveillance and investigation of food source, as well as integration of molecular data. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5654490</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5654490</guid>        </item>
        <item>
            <title>Treatment of Enterohemorrhagic E. coli (EHEC) infection and Hemolytic Uremic Syndrome (HUS)</title>
            <link>http://www.medworm.com/index.php?rid=5654489&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F10%2F12</link>
            <description>In light of the verotoxigenic E. coli (VTEC) European epidemic in 2011, Goldwater and Bettelheim comment on the complex pathogenesis of these strains and recommend a multi-targeted approach to current and future treatment strategies. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5654489</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5654489</guid>        </item>
        <item>
            <title>Cost -effectiveness analysis for clinicians.</title>
            <link>http://www.medworm.com/index.php?rid=5654491&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F10%2F10</link>
            <description>Suzanne Hill comments on the caution required in elucidating cost-effectiveness analysis outcomes, whereby clinicians should consider the benefits and harms in adjusting patient's quality of life years in the use of health care interventions. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5654491</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5654491</guid>        </item>
        <item>
            <title>Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3)</title>
            <link>http://www.medworm.com/index.php?rid=5633652&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F10%2F9</link>
            <description>A novel anti-cancer drug diindolylmethane (DIM) prevents ovarian cancer cell growth by blocking STAT3, and enhances the tumor suppressive effects of the chemotherapy drug cisplatin, providing a potential new therapy for cisplatin-resistant tumors. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5633652</comments>
            <pubDate>Thu, 26 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5633652</guid>        </item>
        <item>
            <title>Clinical evaluation of iron treatment efficiency among non-anemic but iron-deficient female blood donors: 
a randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=5623605&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F10%2F8</link>
            <description>Iron treatment has no significant effect on fatigue symptoms or aerobic capacity in non-anemic blood donors with iron deficiency, suggesting that these donors would not clinically benefit from iron supplementation therapy. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623605</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5623605</guid>        </item>
        <item>
            <title>The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department</title>
            <link>http://www.medworm.com/index.php?rid=5615365&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F10%2F7</link>
            <description>Morgenthaler and colleagues review the recent progress in determining the prognostic and diagnostic value of copeptin, which is released in response to stress, as a biomarker for risk stratification in the emergency department. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615365</comments>
            <pubDate>Fri, 20 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615365</guid>        </item>
        <item>
            <title>Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer</title>
            <link>http://www.medworm.com/index.php?rid=5602484&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F10%2F6</link>
            <description>Evidence from a systematic review and meta-analysis suggests inconclusive predictive value of serum biomarkers for pediatric febrile neutropenic episodes, but further studies for the roles of IL6, IL8 and procalcitonin should be conducted. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5602484</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5602484</guid>        </item>
        <item>
            <title>Towards a genuinely medical model for psychiatric nosology</title>
            <link>http://www.medworm.com/index.php?rid=5590693&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F10%2F5</link>
            <description>With the imminent release of the DSM-5, Nesse and Stein discuss the ways that classifications of disease in psychiatry still fall short of the ideal, and argue for a more medical approach to this subject. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5590693</comments>
            <pubDate>Fri, 13 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5590693</guid>        </item>
        <item>
            <title>Frailty in primary care: a review of its conceptualization and implications for practice</title>
            <link>http://www.medworm.com/index.php?rid=5590694&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F10%2F4</link>
            <description>Lacas and Rockwood review the tools used to assess frailty in elderly patients in the realm of primary care, and address how these tools aide frailty recognition and management, which can impact clinical care. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5590694</comments>
            <pubDate>Wed, 11 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5590694</guid>        </item>
        <item>
            <title>Reversal of type 1 diabetes via islet beta cell regeneration following immune modulation by cord blood-derived multipotent stem cells</title>
            <link>http://www.medworm.com/index.php?rid=5590695&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F10%2F3</link>
            <description>The safe reversal of Type 1 diabetes is possible with Stem Cell Educator therapy which uses stem cells from cord blood to re-educate a diabetic's own T cells, restarts pancreatic function, and reduces the need for insulin. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5590695</comments>
            <pubDate>Tue, 10 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5590695</guid>        </item>
        <item>
            <title>suPAR as a prognostic biomarker in sepsis</title>
            <link>http://www.medworm.com/index.php?rid=5566934&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F10%2F2</link>
            <description>Donadello and colleagues review the clinical utility of suPAR as a biomarker for sepsis, and discuss how it can be used to monitor response to treatment in critically ill patients. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5566934</comments>
            <pubDate>Thu, 05 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5566934</guid>        </item>
        <item>
            <title>Clinical application of stem cell therapy in Parkinson's disease</title>
            <link>http://www.medworm.com/index.php?rid=5566935&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F10%2F1</link>
            <description>Politis and Lindvall review the evidence from clinical trials of human foetal ventral mesencephalic transplantation to treat Parkinson's disease (PD) patients, and review the current status of stem cell therapy, both of which aim to provide long-lasting relief of patients' symptoms. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5566935</comments>
            <pubDate>Wed, 04 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5566935</guid>        </item>
        <item>
            <title>Asymptomatic neurocognitive disorders in patients infected by HIV: 
fact or fiction?</title>
            <link>http://www.medworm.com/index.php?rid=5548631&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F138</link>
            <description>Carlo Torti and colleagues comment on a recent debate in BMC Infectious Diseases about the overestimation of asymptomatic neurological disorders (ANI) incidence in HIV patients, and discuss the importance of developing new tools to accurately monitor these disorders. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5548631</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5548631</guid>        </item>
        <item>
            <title>The Alvarado score for predicting acute appendicitis: A systematic review</title>
            <link>http://www.medworm.com/index.php?rid=5548630&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F139</link>
            <description>Conclusions:
The Alvarado score is a useful diagnostic 'rule out' score at a cut point of 5 for all patient groups. The score is well calibrated in men, inconsistent in children and over-predicts the probability of appendicitis in women across all strata of risk. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5548630</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5548630</guid>        </item>
        <item>
            <title>Peroxiredoxin 4: a multifunctional biomarker worthy of further exploration</title>
            <link>http://www.medworm.com/index.php?rid=5541518&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F137</link>
            <description>In our latest article in the Clinical Biomarkers series, Janin Schulte comments on the enzyme peroxiredoxin 4, an indicator of altered redox environment in acute and chronic infections, and highlights the multiple uses of this enzyme as a prognostic biomarker. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5541518</comments>
            <pubDate>Fri, 23 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5541518</guid>        </item>
        <item>
            <title>Muscle : a source of progenitor cells for bone fracture healing.</title>
            <link>http://www.medworm.com/index.php?rid=5531069&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F136</link>
            <description>Yves Henrotin discusses the importance of the role myogenic progenitor cells may play in the repair of open fractures, as was recently reported by Renjing Liu and colleagues, and comments on how these cells may lead to improved orthopaedic surgical techniques. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5531069</comments>
            <pubDate>Thu, 22 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5531069</guid>        </item>
        <item>
            <title>Acute kidney injury biomarkers: renal angina and the need for a renal troponin I</title>
            <link>http://www.medworm.com/index.php?rid=5531070&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F135</link>
            <description>Novel biomarkers can be used for prognosis of acute kidney injury (AKI), and in our latest addition to the Clinical Biomarkers series, Stuart L Goldstein discusses the importance of such biomarkers in early detection of AKI. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5531070</comments>
            <pubDate>Wed, 21 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5531070</guid>        </item>
        <item>
            <title>Mental disorders as risk factors: assessing the evidence for the global burden of disease study</title>
            <link>http://www.medworm.com/index.php?rid=5510510&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F134</link>
            <description>Findings from the ongoing Global Burden of Disease (GBD) study are discussed by Baxter and colleagues who argue that further research is needed to confirm if mental disorders are risk factors for other diseases, and suggest criteria required for future study designs. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5510510</comments>
            <pubDate>Fri, 16 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5510510</guid>        </item>
        <item>
            <title>Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer</title>
            <link>http://www.medworm.com/index.php?rid=5510511&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F133</link>
            <description>The biomarker septin 9 methylated DNA, which can be detected in blood plasma, provides a promising diagnostic test for colorectal cancer (CRC) of all stages, and can be used to screen for CRC in patients unable to undergo colonoscopy. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5510511</comments>
            <pubDate>Wed, 14 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5510511</guid>        </item>
        <item>
            <title>Biomarkers of acute lung injury: worth their salt?</title>
            <link>http://www.medworm.com/index.php?rid=5499808&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F132</link>
            <description>Griffiths and colleagues discuss the role of biomarkers in the management of acute lung injury, a life-threatening form of hypoxemic respiratory failure, and critically examine the current strategies used to identify biomarkers. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5499808</comments>
            <pubDate>Mon, 12 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5499808</guid>        </item>
        <item>
            <title>Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment</title>
            <link>http://www.medworm.com/index.php?rid=5491346&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F131</link>
            <description>Maltezou and Papa discuss Crimean-Congo hemorrhagic fever (CCHF), factors influencing its incidence and the treatment of this condition, calling for better surveillance and improved treatments. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5491346</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5491346</guid>        </item>
        <item>
            <title>A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses</title>
            <link>http://www.medworm.com/index.php?rid=5481584&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F130</link>
            <description>Diagnosis of Kawasaki disease, an acute vasculitis of infants and young children characterized by an array of symptoms that can mimic other benign conditions, may be easier with a new multi-step algorithm (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5481584</comments>
            <pubDate>Tue, 06 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5481584</guid>        </item>
        <item>
            <title>Non-pharmacological, multicomponent group therapy in patients with degenerative dementia: a 12-month randomised, controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=5463517&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F129</link>
            <description>Group therapy combining regular physical activity, cognitive tasks and active discussion can postpone the progression of cognitive decline in elderly dementia patients, and these therapy sessions appear to be as effective at improving cognitive function as anti-dementia drugs. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5463517</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5463517</guid>        </item>
        <item>
            <title>Brief psychosocial education, not core stabilization, reduced incidence of low back pain: results from the Prevention of Low Back Pain in the Military (POLM) cluster randomized trial</title>
            <link>http://www.medworm.com/index.php?rid=5463518&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F128</link>
            <description>In contrast to core muscle stabilization, which is a traditional lumbar exercise, a brief psychosocial education technique can be a more effective strategy for the primary prevention of low back pain. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5463518</comments>
            <pubDate>Tue, 29 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5463518</guid>        </item>
        <item>
            <title>The control of tuberculosis in large cities in developed countries; an organisational problem</title>
            <link>http://www.medworm.com/index.php?rid=5452966&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F127</link>
            <description>Cayla and Orceau comment on an article published in BMC Public Health analysing efficacy of tuberculosis (TB) management programs in large cities, and discuss the importance of improving organization of such programs. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5452966</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5452966</guid>        </item>
        <item>
            <title>Acute radiation syndrome caused by accidental radiation exposure - therapeutic principles</title>
            <link>http://www.medworm.com/index.php?rid=5446284&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F126</link>
            <description>In the wake of the Fukushima radiation incident, Dorr and Meineke review the therapeutic principles of acute radiation syndrome with special reference to hematopoetic and cutaneous radiation syndromes. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5446284</comments>
            <pubDate>Fri, 25 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5446284</guid>        </item>
        <item>
            <title>Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: A randomized double-blind clinical trial</title>
            <link>http://www.medworm.com/index.php?rid=5446285&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F125</link>
            <description>Endothelial dysfunction may lead to cardiovascular disease, a major cause of death in diabetes type 2 patients, but can be ameliorated by regular consumption of vitamin D fortified yoghurt by improving glycemic status, lipid profile and endothelial biomarkers these subjects. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5446285</comments>
            <pubDate>Thu, 24 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5446285</guid>        </item>
        <item>
            <title>A promising approach in comparative research on care for the elderly</title>
            <link>http://www.medworm.com/index.php?rid=5426810&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F124</link>
            <description>van der Zee and Kroneman comment on research presented in BMC Health Services Research comparing long-term elderly care throughout Europe, and discuss how the study widens knowledge in a neglected but increasingly important area of health services research. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5426810</comments>
            <pubDate>Fri, 18 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5426810</guid>        </item>
        <item>
            <title>A systematic review on the effect of sweeteners on glycemic response and clinically relevant outcomes</title>
            <link>http://www.medworm.com/index.php?rid=5415305&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F123</link>
            <description>There is inadequate evidence for a clear effect of sweetener consumption on glycemic response and weight control, highlighting a need for good quality controlled trials to determine whether they have a clinically relevant outcome. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5415305</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5415305</guid>        </item>
        <item>
            <title>Th17-related cytokines: new players in the control of chronic intestinal inflammation</title>
            <link>http://www.medworm.com/index.php?rid=5415306&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F122</link>
            <description>Monteleone and colleagues review the evidence of how T helper 17 (Th17) cells and the cytokines they produce contribute to inflammatory bowel diseases (IBD) and discuss how this knowledge contributes to new avenues of therapeutic development for these diseases. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5415306</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5415306</guid>        </item>
        <item>
            <title>Trauma networks: present and future challenges</title>
            <link>http://www.medworm.com/index.php?rid=5403973&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F121</link>
            <description>Giannoudis and Kanakaris discuss the formation and development of Regional Trauma Networks in England, including the challenges facing a diverse set of stakeholders, including the public, clinicians and policy makers in order to bring this plan to full implementation. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5403973</comments>
            <pubDate>Fri, 11 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5403973</guid>        </item>
        <item>
            <title>Closed-loop insulin delivery for treatment of type 1 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5394388&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F120</link>
            <description>Daniela Elleri and colleagues review the current status, clinical evaluations and future directions of the artificial pancreas, a closed-loop insulin delivery system using real-time glucose responsive insulin delivery to achieve tight control of glucose in type 1 diabetes patients. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5394388</comments>
            <pubDate>Wed, 09 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5394388</guid>        </item>
        <item>
            <title>Novel pharmacotherapeutic treatments for cocaine addiction</title>
            <link>http://www.medworm.com/index.php?rid=5371863&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F119</link>
            <description>Shorter and Kosten review recent clinical trials and pre-clinical studies in cocaine addiction treatment, highlighting the potential for future therapeutic developments. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5371863</comments>
            <pubDate>Thu, 03 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5371863</guid>        </item>
        <item>
            <title>Mental illness related disparities in diabetes prevalence, quality of care and outcomes: a population-based longitudinal study</title>
            <link>http://www.medworm.com/index.php?rid=5371864&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F118</link>
            <description>Disparities in diabetes prevalence and the quality and outcome of diabetic care of those with mental illness and those without in Australia highlights the need for better, more integrated care for this population. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5371864</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5371864</guid>        </item>
        <item>
            <title>Atrazine-induced apoptosis of splenocytes in BALB/C mice</title>
            <link>http://www.medworm.com/index.php?rid=5371865&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F117</link>
            <description>Atrazine, which is a commonly used herbicide with potentially serious environmental side effects including immune impairment, causes splenic atrophy involving apoptosis of spleen cells, which likely contributes to the mechanism of immunotoxicity. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5371865</comments>
            <pubDate>Thu, 27 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5371865</guid>        </item>
        <item>
            <title>New directions in migraine</title>
            <link>http://www.medworm.com/index.php?rid=5371866&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F116</link>
            <description>Weir and Cader review recent genetic insights into migraine pathogenesis, highlighting that mutations in ion channels and transporters may contribute to pathology, and discussing how these advances will impact future research and therapy for this disease. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5371866</comments>
            <pubDate>Tue, 25 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5371866</guid>        </item>
        <item>
            <title>Q &amp; A: Food additive intolerance</title>
            <link>http://www.medworm.com/index.php?rid=5371867&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F115</link>
            <description>Prof Margitta Worm, a specialist in food allergies and intolerance, discusses food additive intolerance including risk factors, diagnosis and management. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5371867</comments>
            <pubDate>Thu, 20 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5371867</guid>        </item>
        <item>
            <title>The &quot;help&quot; question doesn't help when screening for major depression: External validation of the three-question screening test for primary care patients managed for physical complaints.</title>
            <link>http://www.medworm.com/index.php?rid=5371868&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F114</link>
            <description>Adding a third &quot;help&quot; question to the traditional two question method used by GPs to screen for depression decreases the sensitivity of screening, so is not effective, however, it may be useful in guiding depression management strategy discussions. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5371868</comments>
            <pubDate>Tue, 18 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5371868</guid>        </item>
        <item>
            <title>Sex differences in the morphological failure patterns following hip resurfacing arthroplasty</title>
            <link>http://www.medworm.com/index.php?rid=5371869&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F113</link>
            <description>Hip resurfacing arthroplasty replaces damaged surfaces in the hip joint with metal implants but can sometimes fail, possibly due in part to distinct sex-specific mechanisms, of which better understanding could affect future therapeutic options for selected patient groups. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5371869</comments>
            <pubDate>Thu, 13 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5371869</guid>        </item>
        <item>
            <title>Friedreich ataxia: The vicious circle hypothesis revisited</title>
            <link>http://www.medworm.com/index.php?rid=5371870&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F112</link>
            <description>Rustin and colleagues examine whether the unifying vicious circle hypothesis for Freidreich ataxia, mainly a triplet repeat disorder of the frataxin gene, withstands scrutiny in the face of advances in knowledge about this disease. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5371870</comments>
            <pubDate>Tue, 11 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5371870</guid>        </item>
        <item>
            <title>Public health and medical care for the world's factory: China's Pearl River Delta Region</title>
            <link>http://www.medworm.com/index.php?rid=5371871&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F110</link>
            <description>Fabre and Rodwin discuss the effect of high density urbanization on quality of public health and access to healthcare, focusing on China's pearl river delta region. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5371871</comments>
            <pubDate>Tue, 04 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5371871</guid>        </item>
        <item>
            <title>Procalcitonin for diagnosis of infection and guide to antibiotic
decisions: past, present and future</title>
            <link>http://www.medworm.com/index.php?rid=5244552&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F107</link>
            <description>Mueller and colleagues kick off our new thematic series on Clinical Biomarkers with a review on the utility of procalcitonin in the diagnosis of bacterial infection and decisions about antibiotic treatment in different clinical settings. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5244552</comments>
            <pubDate>Thu, 22 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5244552</guid>        </item>
        <item>
            <title>A functional tandem-repeats polymorphism in the downstream of TERT is associated with the risk of nasopharyngeal carcinoma in Chinese population</title>
            <link>http://www.medworm.com/index.php?rid=5244553&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F106</link>
            <description>Certain polymorphisms in the MNS16A tandem repeat region, located downstream of the telomerase reverse transcriptase (TERT) gene, may contribute to the risk of nasopharyngeal carcinoma (NPC) onset in the Chinese population through modification of TERT expression levels (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5244553</comments>
            <pubDate>Tue, 20 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5244553</guid>        </item>
        <item>
            <title>5-alpha reductase inhibitors and prostate cancer prevention: where do we turn now?</title>
            <link>http://www.medworm.com/index.php?rid=5231101&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F105</link>
            <description>Hamilton and Freedland discuss 5-alpha reductase inhibitors (5-ARIs) and how they have so far failed to live up to their initial promise as prostate cancer chemopreventives as well as what the future should hold for research in this area. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5231101</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5231101</guid>        </item>
        <item>
            <title>Human papillomavirus prevalence amongst Indigenous and non-Indigenous Australian women prior to a national HPV vaccination program</title>
            <link>http://www.medworm.com/index.php?rid=5216547&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F104</link>
            <description>Prevalence of high risk human papilloma virus (HPV) genotypes among Indigenous and non-Indigenous Australian women is similar, suggesting that higher rates of cervical cancer in Indigenous women may be due to poorer access to screening and treatment. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5216547</comments>
            <pubDate>Tue, 13 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5216547</guid>        </item>
        <item>
            <title>Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting</title>
            <link>http://www.medworm.com/index.php?rid=5202037&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F103</link>
            <description>Risk prediction models for type 2 diabetes are generally poorly reported and use weak methods, highlighting a need for improved and specific reporting guidelines suitable for these types of studies to ensure better clinical utility. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5202037</comments>
            <pubDate>Thu, 08 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5202037</guid>        </item>
        <item>
            <title>Emerging therapies for severe asthma</title>
            <link>http://www.medworm.com/index.php?rid=5202038&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F102</link>
            <description>Thomson and colleagues review recent progress in developing viable therapies for severe asthma, including humanized monoclonal antibodies and bronchial thermoplasty, as well as highlighting why future new advances may be genotype/phenotype dependent in this disease. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5202038</comments>
            <pubDate>Tue, 06 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5202038</guid>        </item>
        <item>
            <title>Q &amp; A: The Alzheimer's Disease Neuroimaging Initiative</title>
            <link>http://www.medworm.com/index.php?rid=5189599&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F101</link>
            <description>Paul Aisen, a member of the Alzheimer's Disease Neuroimaging Initiative (ADNI) discusses his experiences and outlines some of the lessons learned that are applicable to other disease researchers. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5189599</comments>
            <pubDate>Wed, 31 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5189599</guid>        </item>
        <item>
            <title>Vocation and avocation: Leisure activities correlate with professional engagement, but not burnout, in a cross-sectional survey of UK doctors</title>
            <link>http://www.medworm.com/index.php?rid=5178597&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F100</link>
            <description>Depersonalisation or 'burnout' is a risk to hard-working doctors due to their high-intensity work, impacting on vocation, or job satisfaction - but this state might be avoided by ensuring doctors' vocations are complemented by an 'avocation' or leisure activity. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5178597</comments>
            <pubDate>Mon, 29 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5178597</guid>        </item>
        <item>
            <title>Advances in the treatment of chronic Myeloid Leukemia</title>
            <link>http://www.medworm.com/index.php?rid=5167506&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F99</link>
            <description>Deininger and colleagues review the efficacy of second generation tyrosine kinase inhibitors (TKI) in chronic myeloid leukemia, new agents for resistant disease and the promise of upcoming third generation TKIs. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5167506</comments>
            <pubDate>Thu, 25 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5167506</guid>        </item>
        <item>
            <title>Epigenetic regulation of caloric restriction in aging</title>
            <link>http://www.medworm.com/index.php?rid=5167507&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F98</link>
            <description>Tollefsbol and colleagues review the evidence for the effect of epigenetic regulation in response to caloric restriction and how it might contribute to clinical advances in treatment and prevention of human aging-associated disease. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5167507</comments>
            <pubDate>Wed, 24 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5167507</guid>        </item>
        <item>
            <title>The &quot;smoker's paradox&quot; in patients with acute coronary syndrome: a systematic review</title>
            <link>http://www.medworm.com/index.php?rid=5153186&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F97</link>
            <description>&quot;Smoker's paradox&quot;, the phenomenon of smokers having lower mortality risk after acute coronary syndrome than non-smokers, was originally observed about two decades ago, however, treatment advances, including routine early invasive management, mean this phenomenon no longer holds true. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5153186</comments>
            <pubDate>Mon, 22 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5153186</guid>        </item>
        <item>
            <title>Integrated post-discharge transitional care in a hospitalist system to improve discharge outcome: An experimental study</title>
            <link>http://www.medworm.com/index.php?rid=5136558&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F96</link>
            <description>Use of an integrated post-discharge transitional care system (PDTC) as a post-hospital discharge follow-up service using disease-specific care, telephone monitoring, hotline counseling, and a hospitalist-run clinic reduces rates of post-discharge readmission and death. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5136558</comments>
            <pubDate>Tue, 16 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5136558</guid>        </item>
        <item>
            <title>What does matrix metalloproteinase-1 expression in patients with breast cancer really tell us?</title>
            <link>http://www.medworm.com/index.php?rid=5115455&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F95</link>
            <description>Mannello introduces matrix metalloproteinase-1 (MMP-1), focusing on an article published this month in BMC Cancer looking at the association of MMP-1 and clinical outcome, highlighting its potential as a biomarker to determine breast cancer prognosis. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5115455</comments>
            <pubDate>Wed, 10 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5115455</guid>        </item>
        <item>
            <title>Buyer  beware? Does the information provided with herbal products available over the counter enable safe use?</title>
            <link>http://www.medworm.com/index.php?rid=5115456&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F94</link>
            <description>Common herbal supplements such as St John's Wort and Ginseng, which may cause side effects and have interactions with conventional medicines, are often not labeled with appropriate safety information for consumers. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5115456</comments>
            <pubDate>Mon, 08 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5115456</guid>        </item>
        <item>
            <title>Reduced perinatal mortality following enhanced training of birth attendants in the Democratic Republic of Congo: a time-dependent effect</title>
            <link>http://www.medworm.com/index.php?rid=5092662&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F93</link>
            <description>Enhanced training of birth attendants in the Democratic Republic of Congo using one of the WHO's established care programs ultimately reduces childbirth mortality rates, and indicates its potential as a low cost intervention in developing countries. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5092662</comments>
            <pubDate>Wed, 03 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5092662</guid>        </item>
        <item>
            <title>Evidence based guidelines for use of probiotics in preterm neonates</title>
            <link>http://www.medworm.com/index.php?rid=5092663&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F92</link>
            <description>Guidelines for probiotic treatment in neonates to reduce the risk of necrotizing enterocolitis should be expanded to include preterm and lowbirth weight babies where appropriate supplements are available. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5092663</comments>
            <pubDate>Mon, 01 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5092663</guid>        </item>
        <item>
            <title>Prevalence of myalgic encephalomyelitis/chronic
fatigue syndrome (ME/CFS) in three regions of
England: a repeated cross-sectional study in primary
care</title>
            <link>http://www.medworm.com/index.php?rid=5074943&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F91</link>
            <description>ME/CFS or chronic fatigue syndrome is a significant burden on health providers so a new call to use definitions consistently will make it easier to classify sub-groups of patients according to treatment needs. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5074943</comments>
            <pubDate>Wed, 27 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5074943</guid>        </item>
        <item>
            <title>Cross-national epidemiology of DSM-IV major depressive episode</title>
            <link>http://www.medworm.com/index.php?rid=5067430&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F90</link>
            <description>Major depression is a significant public health problem around the globe which affects women twice as commonly as men and is most strongly correlated with being separated, divorced or widowed. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5067430</comments>
            <pubDate>Mon, 25 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5067430</guid>        </item>
        <item>
            <title>Can user testing of a clinical trial patient information sheet make it fit-for-purpose? - a randomised controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=5046420&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F89</link>
            <description>User testing of participant information sheets provided to potential volunteers for clinical trials is an effective way of improving their layout and readability, which have been criticized as being obscure and difficult to understand, ensuring that &amp;quot;informed consent&amp;quot; is just that. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5046420</comments>
            <pubDate>Wed, 20 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5046420</guid>        </item>
        <item>
            <title>Simulation of an SEIR infectious disease model on the dynamic contact network of conference attendees</title>
            <link>http://www.medworm.com/index.php?rid=5046422&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F87</link>
            <description>The spread of infectious diseases can be modeled by face-to-face interactions among conference attendees obtained using radiofrequency identification devices, but model design should be considered carefully to properly inform the study and management of real epidemics. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5046422</comments>
            <pubDate>Mon, 18 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5046422</guid>        </item>
        <item>
            <title>The importance of including dynamic social networks when modeling epidemics of airborne infections: does increasing complexity increase accuracy?</title>
            <link>http://www.medworm.com/index.php?rid=5046421&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F88</link>
            <description>Blower and Go comment on the use of dynamic social networks in which to model airborne infectious disease spread, and emphasize that increased complexity of these models does not necessarily increase accuracy. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5046421</comments>
            <pubDate>Mon, 18 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5046421</guid>        </item>
        <item>
            <title>Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science</title>
            <link>http://www.medworm.com/index.php?rid=5025688&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F86</link>
            <description>Interest in the patient's views of his or her illness and treatment has increased dramatically. However, our ability to appropriately measure such issues lags far behind the level of interest and need. Too often such measurement is considered to be a simple and trivial activity that merely requires the application of common sense. However, good quality measurement of patient-reported outcomes is a complex activity requiring considerable expertise and experience. This review considers the most important issues related to such measurement in the context of chronic disease and details how instruments should be developed, validated and adapted for use in additional languages. While there is often consensus on how best to undertake these activities, there is generally little evidence to support...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5025688</comments>
            <pubDate>Wed, 13 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5025688</guid>        </item>
        <item>
            <title>Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes.</title>
            <link>http://www.medworm.com/index.php?rid=5015785&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F85</link>
            <description>Background:
Hypovitaminosis D has been recently recognized as a worldwide epidemic. Since vitamin D exerts significant metabolic activities, comprising free fatty acids (FFA) flux regulation from the periphery to the liver, its deficiency may promote fat deposition into the hepatocytes. Aim of our study was to test the hypothesis of a direct association between hypovitaminosis D and the presence of NAFLD in subjects with various degree of insulin-resistance and related metabolic disorders.
Methods:
We studied 262 consecutive subjects referred to the Diabetes and Metabolic Diseases clinics for metabolic evaluation. NAFLD (non-alcoholic fatty liver disease) was diagnosed by upper abdomen ultrasonography, metabolic syndrome was identified according to the Third Report of National Cholesterol ...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5015785</comments>
            <pubDate>Mon, 11 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5015785</guid>        </item>
        <item>
            <title>Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world</title>
            <link>http://www.medworm.com/index.php?rid=5015786&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F84</link>
            <description>Conclusions:
The comparative approach followed here is helpful in understanding the various models selected and will thus benefit (low-income) countries in designing their own cost-effectiveness analyses using new or adapted existing models. Potential users of the models in low and middle income countries need to consider results from existing studies and reviews. The comparative approach followed here is helpful in understanding the various models selected and will thus benefit (low-income) countries in designing their own costeffectiveness analyses using new or adapted existing models. Potential users of the models in low and middle income countries need to consider results from existing studies and reviews. There will be a need for contextualisation including the use of country specific...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5015786</comments>
            <pubDate>Thu, 07 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5015786</guid>        </item>
        <item>
            <title>Treating frailty. A practical guide.</title>
            <link>http://www.medworm.com/index.php?rid=5004640&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F83</link>
            <description>Frailty is a common syndrome that is associated with vulnerability to poor health outcomes. Frail older people have increased risk of morbidity, institutionalization and death, resulting in burden to individuals, their families, health care services and society. Assessment and treatment of the frail individual provide many challenges to clinicians working with older people. Despite frailty being increasingly recognized inthe literature, there is a paucity of direct evidence to guide interventions to reduce frailty. In this paper we review methods for identification of frailty in the clinical setting, propose a model for assessment of the frail older person and summarize thecurrent best evidence for treating the frail older person. We provide an evidencebased framework that can be used to g...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5004640</comments>
            <pubDate>Tue, 05 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5004640</guid>        </item>
        <item>
            <title>MIA is a potential biomarker for tumor load in neurofibromatosis type 1</title>
            <link>http://www.medworm.com/index.php?rid=4996680&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F82</link>
            <description>Conclusions:
MIA is a potential serum biomarker of tumor load in NF1 patients which could be useful in following the disease course and monitoring efficacy of therapies. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4996680</comments>
            <pubDate>Sun, 03 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4996680</guid>        </item>
        <item>
            <title>The impact of diabetes on tuberculosis treatment outcomes: A systematic review</title>
            <link>http://www.medworm.com/index.php?rid=4990227&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F81</link>
            <description>Conclusions:
Diabetes increases the risk of failure and death combined, death, and relapse among patients with tuberculosis. This study highlights a need for increased attention to treatment of tuberculosis in people with diabetes, which may include testing for suspected diabetes, improved glucose control, and increased clinical and therapeutic monitoring. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4990227</comments>
            <pubDate>Thu, 30 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4990227</guid>        </item>
        <item>
            <title>Tinnitus in elderly patients and prognosis of mild-to-moderate congestive heart failure: a cross-sectional study with a long-term extension of the clinical follow-up</title>
            <link>http://www.medworm.com/index.php?rid=4981195&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F80</link>
            <description>Background:
The complex mechanism responsible for tinnitus, a symptom highly prevalent in elderlypatients, could involve an impaired control of the microcirculation of the inner ear,particularly in patients with poor blood pressure control and impaired left ventricular (LV)function.
Methods:
In order to define the relationship between the presence of tinnitus and the severity andclinical prognosis of mild-to-moderate chronic heart failure (CHF) in a large population ofelderly patients (N = 958), a cross-sectional study was conducted with a long-termextension of the clinical follow-up. Blood pressure, echocardiographic parameters, brainnatriuretic peptide (BNP), hospitalization, and mortality for CHF were measured.Multivariate logistic regression analysis was used to assess the association ...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4981195</comments>
            <pubDate>Tue, 28 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4981195</guid>        </item>
        <item>
            <title>Network meta-analysis - highly attractive but more methodological research is needed</title>
            <link>http://www.medworm.com/index.php?rid=4973778&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F79</link>
            <description>Network meta-analysis, in the context of a systematic review, is a meta-analysis in which multiple treatments (that is, three or more) are being compared using both direct comparisons of interventions within randomized controlled trials and indirect comparisons across trials based on a common comparator. To ensure validity of findings from network meta-analyses, the systematic review must be designed rigorously and conducted carefully. Aspects of designing and conducting a systematic review for network meta-analysis include defining the review question, specifying eligibility criteria, searching for and selecting studies, assessing risk of bias and quality of evidence, conducting a network meta-analysis, interpreting and reporting findings. This commentary summarizes the methodologic chall...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4973778</comments>
            <pubDate>Sun, 26 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4973778</guid>        </item>
        <item>
            <title>Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention:  a comparison of methods in a retrospective cohort study</title>
            <link>http://www.medworm.com/index.php?rid=4966228&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F78</link>
            <description>Conclusions:
Although propensity-score methods suggested a mortality benefit with DES, consistent with prior observational studies, a stent era comparison failed to support this conclusion. Unobserved factors influencing stent selection in observational studies likely account for the observed mortality benefit of DES not seen in randomized clinical trials. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4966228</comments>
            <pubDate>Thu, 23 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4966228</guid>        </item>
        <item>
            <title>Problematic Internet Usage in US College Students: A Pilot Study</title>
            <link>http://www.medworm.com/index.php?rid=4958399&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F77</link>
            <description>Conclusion:
The prevalence of problematic Internet usage among US college students is a cause for concern, and potentially requires intervention and treatment amongst the most vulnerable groups. The prevalence reported in this study is lower than that which has been reported in other studies, however the at-risk population is very high and preventative measures are also recommended. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4958399</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4958399</guid>        </item>
        <item>
            <title>Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh Cohort 2): a decade of an epidemic</title>
            <link>http://www.medworm.com/index.php?rid=4950463&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F76</link>
            <description>Conclusion:
Comparisons of our findings with earlier data show that the prevalence of DMT2, hypertension and CAD in Riyadh, Saudi Arabia, has alarmingly worsened. Aggressive promotion of public awareness, continued screening and early intervention are pivotal to boosting a positive response. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4950463</comments>
            <pubDate>Sun, 19 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4950463</guid>        </item>
        <item>
            <title>Best practice for motor imagery: A systematic literature review on motor imagery training elements in
five different disciplines</title>
            <link>http://www.medworm.com/index.php?rid=4943322&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F75</link>
            <description>Conclusions:
MITS elements of successful interventions were individual, supervised and non-directed sessions, added after physical practice. Successful design characteristics were dominant in the Psychology literature, in interventions focusing on motor and strength-related tasks, in interventions with participants aged 20 to 29 years old, and in MI interventions including participants of both genders. Systematic searching of the MI literature was constrained by the lack of a defined MeSH term. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4943322</comments>
            <pubDate>Thu, 16 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4943322</guid>        </item>
        <item>
            <title>Efficacy of Aerobic Exercise and a Prudent Diet for Improving Selected Lipids and Lipoproteins in Adults: A Meta-Analysis of Randomized Controlled Trials</title>
            <link>http://www.medworm.com/index.php?rid=4930283&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F74</link>
            <description>Conclusions: Aerobic exercise combined with a prudent diet is highly efficacious for improving TC, TC:HDL-C, LDL-C and TG, but not HDL-C concentrations, in adults. However, additional studies are needed, including effectiveness studies using intention-to-treat analysis. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4930283</comments>
            <pubDate>Tue, 14 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4930283</guid>        </item>
        <item>
            <title>High prevalence of potential biases threatens the interpretation of trials in patients with chronic disease</title>
            <link>http://www.medworm.com/index.php?rid=4930284&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F73</link>
            <description>Conclusion:
Our survey showed that an alarmingly large proportion of chronic disease trials do not define a primary outcome, do not use appropriate methods for subgroup analyses or use naive methods to handle missing data, if at all. As a consequence, biases are likely to be introduced in many trials on widely prescribed treatments in patients with chronic disease. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4930284</comments>
            <pubDate>Sun, 12 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4930284</guid>        </item>
        <item>
            <title>Advances in understanding and treating ADHD</title>
            <link>http://www.medworm.com/index.php?rid=4918809&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F72</link>
            <description>Attention deficit/hyperactive disorder (ADHD) is a neurocognitive behavioural developmental disorder most commonly seen in childhood and adolescence, which often extends to the adult years. Relative to a decade ago, there has been extensive research into understanding the factors underlying ADHD leading to far more treatment options available for both youths and adults with this disorder. Novel stimulant formulations have made it possible to tailor treatment to the duration of efficacy required by patients and to help mitigate the potential for abuse, misuse and diversion. Several new non-stimulant options have also emerged in the past few years. Amongst these, cognitive behavioral interventions have proven popular in the treatment of adult ADHD, especially within the adult population who ...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4918809</comments>
            <pubDate>Thu, 09 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4918809</guid>        </item>
        <item>
            <title>FTO gene polymorphisms and obesity risk: a meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=4909262&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F71</link>
            <description>Conclusions:
This meta-analysis suggests that FTO may represent a low-penetrance susceptible gene for obesity risk. Individual studies with large sample size are needed to further evaluate the associations between the polymorphisms and obesity risk in various ethnic populations. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4909262</comments>
            <pubDate>Tue, 07 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4909262</guid>        </item>
        <item>
            <title>Role of Lifestyle Changes in the Management of Chronic Liver Disease</title>
            <link>http://www.medworm.com/index.php?rid=4900072&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F70</link>
            <description>The prevalence of obesity worldwide has dramatically increased during the last three decades. With obesity comes a variety of adverse health outcomes which are grouped under the umbrella of metabolic syndrome. The liver in particular seems to be significantly impacted by fat deposition in the presence of obesity. In this article we discuss several liver conditions which are directly affected by overweight and obese status, including nonalcoholic fatty liver disease, chronic infection with hepatitis C virus and post-liver transplant status. The deleterious effects of obesity on liver disease and overall health can be significantly impacted by a culture that fosters sustained nutritional improvement and regular physical activity. Here we summarize the current evidence supporting nonpharmacol...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4900072</comments>
            <pubDate>Sun, 05 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4900072</guid>        </item>
        <item>
            <title>alpha-Mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation</title>
            <link>http://www.medworm.com/index.php?rid=4900073&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F69</link>
            <description>Conclusions:
Since lymph node involvement is the most important prognostic factor in breast cancer patients, the antimetastatic activity of alpha-mangostin as detected in mammary cancers carrying a p53 mutation in the present study may have specific clinical applications. In addition, alpha-mangostin may have chemopreventive benefits and/or prove useful as an adjuvant therapy, or as a complementary alternative medicine in the treatment of breast cancer. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4900073</comments>
            <pubDate>Thu, 02 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4900073</guid>        </item>
        <item>
            <title>Differential properties of human ACL and MCL stem cells may be responsible for their differential healing capacity</title>
            <link>http://www.medworm.com/index.php?rid=4890047&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F68</link>
            <description>Conclusions:
This study shows for the first time that hACL-SCs are intrinsically different from hMCL-SCs. We suggest that the differences in their properties contribute to the known disparity in healing capabilities between the two ligaments. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4890047</comments>
            <pubDate>Wed, 01 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4890047</guid>        </item>
        <item>
            <title>Predicting Streptococcal Pharyngitis in Adults in Primary Care: A Systematic Review of the Diagnostic Accuracy of Symptoms and Signs and Validation of the Centor Score</title>
            <link>http://www.medworm.com/index.php?rid=4890048&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F67</link>
            <description>Conclusions:
Individual signs and symptoms are not powerful enough to discriminate GABHS pharyngitis from other types of sore throat. The Centor Score is a well calibrated CPR for estimating the probability of GABHS pharyngitis. The Centor score can enhance appropriate prescribing of antibiotics but should be used with caution in low prevalence settings of GABHS pharyngitis such as primary care. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4890048</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4890048</guid>        </item>
        <item>
            <title>Bone Regeneration: Current Concepts and Future Directions.</title>
            <link>http://www.medworm.com/index.php?rid=4882140&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F66</link>
            <description>Bone regeneration is a complex well-orchestrated physiological process of bone formation seeing during normal fracture healing or continuous remodelling throughout adult life. However, there are complex clinical conditions in which bone regeneration is required in large quantity for skeletal reconstruction of large bone defects created by trauma, infection, tumour resection and skeletal abnormalities; or cases in which the regenerative process is compromised, including avascular necrosis, atrophic non-unions and osteoporosis. Currently, there is a plethora of different strategies to augment the impaired or &quot;insufficient&quot; bone regeneration process, including the &quot;gold standard&quot; autologous bone graft, free fibula vascularised graft, allograft implantation, the use of growth factors, osteocon...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4882140</comments>
            <pubDate>Mon, 30 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4882140</guid>        </item>
        <item>
            <title>A perspective on SIDS pathogenesis. The hypotheses: plausibility and evidence</title>
            <link>http://www.medworm.com/index.php?rid=4869413&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F64</link>
            <description>Several theories of the underlying mechanisms of Sudden Infant Death Syndrome (SIDS) have been proposed. These theories have born relatively narrow beach-head research programs attracting generous research funding sustained for many years at expense to the public purse. This perspective endeavors to critically examine the evidence and bases of these theories and determine their plausibility; and questions whether or not a safe and reasoned hypothesis lies at their foundation. The Opinion sets specific criteria by asking the following questions: 1. Does the hypothesis take into account the key pathological findings in SIDS? 2. Is the hypothesis congruent with the key epidemiological risk factors? 3. Does it link 1 and 2? Falling short of any one of these answers, by inference, would imply i...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4869413</comments>
            <pubDate>Thu, 26 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4869413</guid>        </item>
        <item>
            <title>Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications</title>
            <link>http://www.medworm.com/index.php?rid=4859863&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F63</link>
            <description>Soft tissue sarcomas of childhood are a group of heterogeneous tumors thought to be derived from mesenchymal stem cells. Surgical resection is effective only in about 50% of cases and resistance to conventional chemotherapy is often responsible for treatment failure. Therefore, investigations on novel therapeutic targets are of fundamental importance. Deregulation of epigenetic mechanisms underlying chromatin modifications during stem cell differentiation has been suggested to contribute to soft tissue sarcoma pathogenesis. One of the main players in this scenario is EZH2, a methyltransferase belonging to the Polycomb Group proteins. EZH2 catalyzes histone H3 methylation on gene promoters thus repressing genes that induce stem cell differentiation to maintain an embryonic stem cell signatu...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4859863</comments>
            <pubDate>Tue, 24 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4859863</guid>        </item>
        <item>
            <title>Mitochondrial Oxidative Stress Drives Tumor Progression and Metastasis: Should We Use Antioxidants As A Key Component of Cancer Treatment and Prevention?</title>
            <link>http://www.medworm.com/index.php?rid=4851576&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F62</link>
            <description>The functional role of oxidative stress in cancer pathogenesis has long been a hotly debated topic. A study published this month in BMC Cancer by Goh et al., directly addresses this issue by using a molecular genetic approach, via an established mouse animal model of human breast cancer. More specifically, alleviation of mitochondrial oxidative stress, via transgenic over-expression of catalase (an anti-oxidant enzyme) targeted to mitochondria, was sufficient to lower tumor grade (from high-to-low) and to dramatically reduce metastatic tumor burden by &gt;12-fold. Here, we discuss these new findings and place them in the context of several other recent studies showing that oxidative stress directly contributes to tumor progression and metastasis. These results have important clinical and tran...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4851576</comments>
            <pubDate>Sun, 22 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4851576</guid>        </item>
        <item>
            <title>Early infant HIV-1 diagnosis programs in resource limited settings: opportunities for improved outcomes and more cost-effective interventions</title>
            <link>http://www.medworm.com/index.php?rid=4846478&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F59</link>
            <description>Early infant diagnosis (EID) of HIV-1 infection confers substantial benefits to HIV-infected and HIV-uninfected infants, to their families, and to programs providing prevention of mother-to-child transmission (PMTCT) services, but has been challenging to implement in resource-limited settings. In order to correctly inform parents/caregivers of infant infection status and link HIV-infected infants to care and treatment, a &quot;cascade&quot; of events must successfully occur. A frequently-cited barrier to expansion of EID programs is the cost of the required laboratory assays. However, substantial implementation barriers, as well as personnel and infrastructure requirements, exist at each step in the cascade. In this update, we review challenges to uptake at each step in the EID cascade, highlighting...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4846478</comments>
            <pubDate>Thu, 19 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4846478</guid>        </item>
        <item>
            <title>Response: Infant EEG activity as a biomarker for autism: A promising approach or a false promise?</title>
            <link>http://www.medworm.com/index.php?rid=4846477&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F60</link>
            <description>Correspondence - no abstractPlease see research article: http://www.biomedcentral.com/1741-7015/9/18 and commentary article: http://www.biomedcentral.com/1741-7015/9/61 (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4846477</comments>
            <pubDate>Thu, 19 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4846477</guid>        </item>
        <item>
            <title>Infant EEG activity as a biomarker for autism: A promising approach or a false promise?</title>
            <link>http://www.medworm.com/index.php?rid=4846476&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F61</link>
            <description>We describe the approach of Bosl et al and examine their results with respect to baseline prevalence rates, the inclusion of which is necessary to distinguish infants with a biological risk of autism from typically developing infants with a sibling with autism. This is an important distinction that should not be overlooked.Please see research article: http://www.biomedcentral.com/1741-7015/9/18 and correspondence article: http://www.biomedcentral.com/1741-7015/9/60 (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4846476</comments>
            <pubDate>Thu, 19 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4846476</guid>        </item>
        <item>
            <title>Do hospitalist physicians improve the quality of 
inpatient care delivery? A systematic review of process, 
efficiency and outcome measures</title>
            <link>http://www.medworm.com/index.php?rid=4838024&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F58</link>
            <description>Conclusions:
: Future research should include an expanded focus on the specific structures of care that differentiate hospitalists from other inpatient physician groups and the development of better conceptual and statistical models that identify and measure underlying mechanisms driving provider-outcome associations in quality. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4838024</comments>
            <pubDate>Tue, 17 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4838024</guid>        </item>
        <item>
            <title>Predictive factors of urinary tract infections among the oldest old in the general population. A population-based prospective follow-up study.</title>
            <link>http://www.medworm.com/index.php?rid=4826889&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F57</link>
            <description>Conclusions:
Within the oldest old, a history of UTI between the age of 85 and 86 years, cognitive impairment, ADL disability and urine incontinence are independent predictors of developing UTI. These predictive factors could be used to target preventive measures to the oldest old at high risk of UTI. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4826889</comments>
            <pubDate>Sun, 15 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4826889</guid>        </item>
        <item>
            <title>A decision aid to rule-out pneumonia and reduce unnecessary prescriptions of antibiotics in primary care patients with cough and fever</title>
            <link>http://www.medworm.com/index.php?rid=4818474&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F56</link>
            <description>Conclusions:
Following validation and confirmation in new patient samples, this tool could help ruling-out pneumonia and to reduce unnecessary antibiotic prescriptions in patients presenting with cough and fever in primary care. The algorithm might be especially useful in those instances where history taking and physical examination alone are inconclusive for ruling out pneumonia. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4818474</comments>
            <pubDate>Thu, 12 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4818474</guid>        </item>
        <item>
            <title>Cost effectiveness of pediatric pneumococcal conjugate vaccines: a
comparative assessment of decision-making tools</title>
            <link>http://www.medworm.com/index.php?rid=4818477&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F53</link>
            <description>Conclusion:
Vaccine cost (dose price and number of doses). vaccine efficacy and epidemiology of critical endpoint (e.g. incidence of pneumonia, distribution of serotypes causing pneuomia) influential parameters in the models we compared. Understanding differences and similarities of such CE tools through regular comparisons could render decision making processes in different countries more efficient, as well as provide guiding information for further clinical and epidemiological research. A tool comparison exercise using standardized data sets can help model developers to be more transparent about their model structure and assumptions and provide analysts and decision makers with a more in-depth view behind the disease dynamics. Adherence to the WHO guide of economic evaluations of immuniz...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4818477</comments>
            <pubDate>Wed, 11 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4818477</guid>        </item>
        <item>
            <title>Human papillomavirus vaccine introduction in low and middle income countries: guidance on the use of cost-effectiveness models</title>
            <link>http://www.medworm.com/index.php?rid=4818476&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F54</link>
            <description>Conclusions:
The results indicated the usefulness of considering results from several models and sets of modelling assumptions in decision making. Modelling groups were prepared to share their models and expertise to work with stakeholders in developing countries.Please see related article: http://www.biomedcentral.com/1741-7007/9/55. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4818476</comments>
            <pubDate>Wed, 11 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4818476</guid>        </item>
        <item>
            <title>Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal</title>
            <link>http://www.medworm.com/index.php?rid=4818475&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F55</link>
            <description>The objectives of these assessments are to provide decision makers with a menu of existing CE tools for vaccines and their characteristics rather than to endorse the use of a single tool. The outcome will provide policy makers in LMICs with information about the feasibility of applying these models to inform their own decision making. We argue that if models and CE analyses are used to inform decisions, they ought to be critically appraised beforehand, including a transparent evaluation of their structure, assumptions and data sources (in isolation or in comparison to similar tools), so that decision makers can use them while being fully aware of their robustness and limitations. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4818475</comments>
            <pubDate>Wed, 11 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4818475</guid>        </item>
        <item>
            <title>Optimising functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease</title>
            <link>http://www.medworm.com/index.php?rid=4810826&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F50</link>
            <description>Clinical trials aiming to assess the safety and efficacy of foetal cell transplantation in Parkinson's disease rely on the hypothesis that the grafted tissue will survive and grow, restore striatal dopaminergic neurotransmission, improve the connectivity between striatum, thalamus and cortex and thereby produce long-lasting clinical improvement whilst avoiding the development of adverse effects. Although transplantation of human foetal ventral mesencephalic tissue has been reported as one of the most effective reparative therapies in Parkinson's disease patients to date, different studies have shown inconsistent results causing a paucity of new trials over the last decade. However, during this period, functional imaging alongside other scientific developments from clinical observations and...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4810826</comments>
            <pubDate>Mon, 09 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4810826</guid>        </item>
        <item>
            <title>Novel approaches for immune reconstitution and adaptive immune modeling with human pluripotent stem cells</title>
            <link>http://www.medworm.com/index.php?rid=4810825&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F51</link>
            <description>Pluripotent stem cells have the capacity to generate all cell lineages, and substantial progress has been made in realizing this potential. One fascinating but as yet unrealized possibility is the differentiation of pluripotent stem cells into thymic epithelial cells. The thymus is a primary lymphoid organ essential for naive T cell generation. T cells play an important role in adaptive immunity, and their loss or dysfunction is underlies in a wide range of autoimmune and infectious diseases. T cells are generated and selected through interaction with thymic epithelial cells, the functionally essential element of thymus. The ability to generate functional thymic epithelial cells from pluripotent stem cells would have applications in modeling human immune responses in mice, in tissue transp...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4810825</comments>
            <pubDate>Mon, 09 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4810825</guid>        </item>
        <item>
            <title>Clinical Trials for Stem Cell Therapies</title>
            <link>http://www.medworm.com/index.php?rid=4810824&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F52</link>
            <description>In recent years, clinical trials with stem cells have taken the emerging field in many new directions. While numerous teams continue to refine and expand the role of bone marrow and cord blood stem cells for their vanguard uses in blood and immune disorders, many others are looking to expand the uses of the various types of stem cells found in bone marrow and cord blood, in particular mesenchymal stem cells, to uses beyond those that could be corrected by replacing cells in their own lineage. Early results from these trials have produced mixed results often showing minor or transitory improvements that may be attributed to extracellular factors. More research teams are accelerating the use of other types of adult stem cells, in particular neural stem cells for diseases where beneficial out...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4810824</comments>
            <pubDate>Mon, 09 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4810824</guid>        </item>
        <item>
            <title>Perceptions of general practitioners towards the use of a new system for treating back pain: a qualitative interview study</title>
            <link>http://www.medworm.com/index.php?rid=4801041&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F49</link>
            <description>Conclusion:
We conclude that the key obstacle to implementation of the new subgrouping for targeted treatment system for low back pain in primary care was an initial failure to achieve 'coherence' of the desired practice change with GPs. Despite this, GPs used the tool to different degrees, though this signified a general commitment to participating in the study rather than a deeper attitude change towards the new system. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4801041</comments>
            <pubDate>Sun, 08 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4801041</guid>        </item>
        <item>
            <title>Metabolic syndrome: definitions and controversies</title>
            <link>http://www.medworm.com/index.php?rid=4787002&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F48</link>
            <description>Metabolic syndrome (MetS) is a complex disorder defined by a cluster of interconnected factors that increase the risk of cardiovascular atherosclerotic diseases and diabetes mellitus type 2. Currently several different definitions of the MetS exist, causing substantial confusion, as to whether they identify the same individuals or represent a surrogate of risk factors. Recently, a number of other factors, besides those traditionally used to define MetS, that are also linked to the syndrome have been identified. In this review we critically consider existing definitions and evolving information, and conclude that there is still a need to develop uniform criteria to define MetS enabling comparisons between different studies in the hope to better predict patients at risk. As the application o...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4787002</comments>
            <pubDate>Wed, 04 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4787002</guid>        </item>
        <item>
            <title>Should Global Burden of Disease Estimates Include Depression as a Risk Factor for Coronary Heart Disease?</title>
            <link>http://www.medworm.com/index.php?rid=4778990&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F47</link>
            <description>Discussion: Research has now established a strong and consistent effect size in the relationship between major depression and coronary heart disease. Prospective cohort and case-control studies have demonstrated appropriate temporality in the relationship between pre-existing depression and incident coronary heart disease. A dose response relationship appears to exist and plausible biological pathways have been proposed. However, a number of challenges exist when conducting a rigorous assessment of the literature including heterogeneity issues, definition and measurement of depression and coronary heart disease, publication bias and residual confounding. Summary: The current evidence satisfies established criteria for considering depression as an independent risk factor in development of c...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4778990</comments>
            <pubDate>Mon, 02 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4778990</guid>        </item>
        <item>
            <title>Comparison of user groups' perspectives of barriers and facilitators to implementing electronic health records: a systematic review</title>
            <link>http://www.medworm.com/index.php?rid=4761709&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F46</link>
            <description>Conclusions:
This systematic review presents innovative research on the barriers and facilitators to EHR implementation. While important similarities between user groups are highlighted, differences between them demonstrate that each user group also has a unique perspective of the implementation process that should be taken into account. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4761709</comments>
            <pubDate>Wed, 27 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4761709</guid>        </item>
        <item>
            <title>Studying technology use as social practice: the untapped potential of ethnography</title>
            <link>http://www.medworm.com/index.php?rid=4757665&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F45</link>
            <description>Information and communications technologies (ICTs) in healthcare are often introduced with expectations of higher-quality, more efficient, and safer care. Many fail to meet these expectations. We argue here that the well-documented failures of ICTs in healthcare are partly attributable to the philosophical foundations of much health informatics research. Positivistic assumptions underpinning the design, implementation and evaluation of ICTs (in particular the notion that technology X has an 'impact' which can be measured and reproduced in new settings), and the deterministic experimental and quasi-experimental study designs which follow from these assumptions, have inherent limitations when ICTs are part of complex social practices involving multiple human actors. We suggest that whilst ex...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4757665</comments>
            <pubDate>Tue, 26 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4757665</guid>        </item>
        <item>
            <title>Access to a polymerase chain reaction assay method targeting 13 respiratory viruses can reduce antibiotics: a randomised, controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=4752070&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F44</link>
            <description>Conclusions:
Access to a rapid method for etiologic diagnosis of ARTIs may reduce antibiotic prescription rates at initial visit in an outpatient setting. To sustain this effect, however, it seems necessary to better define how to follow and manage the patient according to the result of the test, which warrants further investigation.Trial registration: ClinicalTrials.gov Identifier: NCT01133782 (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4752070</comments>
            <pubDate>Mon, 25 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4752070</guid>        </item>
        <item>
            <title>Circulating tumor cells in breast cancer: A tool whose time has come of age</title>
            <link>http://www.medworm.com/index.php?rid=4740489&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F43</link>
            <description>Circulating tumor cells (CTCs) are isolated tumor cells disseminated from the site of disease in metastatic and/or primary cancers, including breast cancer, that can be identified and measured in the peripheral blood of patients. As recent technical advances have rendered it easier to reproducibly and repeatedly sample this population of cells with a high degree of accuracy, these cells represent an attractive surrogate marker of the site of disease.Currently, CTCs are being integrated into clinical trial design as a surrogate for phenotypic and genotypic markers in correlation with development of molecularly targeted therapies. As CTCs play a crucial role in tumor dissemination, translational research is implicating CTCs in several biological processes, including epithelial to mesenchymal...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4740489</comments>
            <pubDate>Wed, 20 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4740489</guid>        </item>
        <item>
            <title>Combinations of motor measures more strongly predict adverse health outcomes in old age: the rush memory and aging project, a community-based cohort study</title>
            <link>http://www.medworm.com/index.php?rid=4740490&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F42</link>
            <description>ObjectiveMotor impairment in old age is a growing public-health concern, and several different constructs have been used to identify motor impairments in older people. We tested the hypothesis that combinations of motor constructs more strongly predict adverse health outcomes in older people.
Methods:
In total, 949 people without dementia, history of stroke or Parkinson's disease, who were participating in the Rush Memory and Aging Project (a longitudinal community-based cohort study), underwent assessment at study entry. From this, three constructs were derived: 1) physical frailty based on grip strength, timed walk, body mass index and fatigue; 2) Parkinsonian Signs Score based on the modified motor section of the Unified Parkinson's Disease Rating Scale; and 3) a motor construct, based ...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4740490</comments>
            <pubDate>Tue, 19 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4740490</guid>        </item>
        <item>
            <title>Revisiting the technical validation of tumour biomarker assays: How to open a Pandora's box</title>
            <link>http://www.medworm.com/index.php?rid=4730668&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F41</link>
            <description>A tumour biomarker is a characteristic that is objectively measured and evaluated in tumour samples as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. The development of a biomarker contemplates distinct phases including discovery by hypothesis generating preclinical or exploratory studies, development and qualification of the assay for the identification of the biomarker in clinical samples, and validation of its clinical significance. Although guidelines for the development and validation of biomarkers are available, their implementation is challenging, owing to the diversity of biomarkers being developed. The term validation undoubtedly has several meanings, however in the context of biomarker research, a test ...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4730668</comments>
            <pubDate>Mon, 18 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4730668</guid>        </item>
        <item>
            <title>L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot study</title>
            <link>http://www.medworm.com/index.php?rid=4730669&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F40</link>
            <description>Conclusions:
Four-week L-lysine treatment, 6 g/day, caused a significant increase in blood concentration of L-lysine that was well tolerated. Patients showed a significant decrease in positive symptoms as assessed by PANSS in addition to self-reported symptom improvement by three patients. The NO-signalling pathway is an interesting, potentially new treatment target for schizophrenia, however the effects of L-lysine need further evaluation to decide its' potentially beneficial effects on symptom severity in schizophrenia.Trial registration: NCT00996242 (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4730669</comments>
            <pubDate>Sun, 17 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4730669</guid>        </item>
        <item>
            <title>Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis</title>
            <link>http://www.medworm.com/index.php?rid=4713303&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F38</link>
            <description>Conclusions:
Over 90% of patients with OA are at increased GI and/or CV risk. In over half of these patients, the prescription of NSAIDs was not in accordance with current guidelines or recommendations madeby regulatory agencies. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4713303</comments>
            <pubDate>Wed, 13 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4713303</guid>        </item>
        <item>
            <title>Using framework-based synthesis for conducting reviews of qualitative studies</title>
            <link>http://www.medworm.com/index.php?rid=4713302&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F39</link>
            <description>Framework analysis is a technique used for data analysis in primary qualitative research. Recent years have seen its being adapted to conduct syntheses of qualitative studies. Framework-based synthesis shows considerable promise in addressing applied policy-questions. An innovation in the approach, known as &quot;best fit&quot; framework synthesis, has been published in BMC Medical Research Methodology this month. It involves reviewers in choosing a conceptual model likely to be suitable for the question of the review, and using it as the basis of their initial coding framework. This framework is then modified in response to the evidence reported in the studies in the reviews, so that the final product is a revised framework that may include both modified factors and new factors that were not antici...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4713302</comments>
            <pubDate>Wed, 13 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4713302</guid>        </item>
        <item>
            <title>Increasing malaria hospital admissions in Uganda between 
1999 and 2009</title>
            <link>http://www.medworm.com/index.php?rid=4708164&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F37</link>
            <description>Background:
Some areas of Africa are witnessing a malaria transition, in part due to escalated international donor support and intervention coverage. Areas where declining malaria have been observed are largely characterized by relatively low baseline transmission intensity and rapid scaling of interventions. Less well described are changing patterns of malaria burden in areas of high parasite transmission and slower increases in control and treatment access.
Methods:
Uganda is a country predominantly characterised by intense, perennial malaria transmission. Monthly paediatric admission data from five Ugandan hospitals and their catchments have been assembled retrospectively across 11 years from January 1999 to December 2009. Malaria admission rates adjusted for changes in population densi...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4708164</comments>
            <pubDate>Tue, 12 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4708164</guid>        </item>
        <item>
            <title>Risk of infection in patients with lymphoma receiving Rituximab: systematic review and meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=4702349&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F36</link>
            <description>Conclusion:
R-C is superior to standard C in terms of overall response and it does not increase the overall incidence of severe infection. However data on special groups of patients (e.g.: HIV positive subjects and HBV carriers) are lacking. In our opinion more studies are needed to explore the potential effect of R on silent and chronic viral infections. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4702349</comments>
            <pubDate>Mon, 11 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4702349</guid>        </item>
        <item>
            <title>Neuromuscular training with injury prevention counseling to decrease the risk of acute musculoskeletal injury in young men during military service: A population-based randomized study</title>
            <link>http://www.medworm.com/index.php?rid=4702350&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F35</link>
            <description>Conclusions:
A neuromuscular training and injury prevention counselling programme was effective in preventing acute ankle and upper-extremity injuries in young male army conscripts. A similar programme could be useful for all young individuals by initiating a regular exercise routine.Trial registration: The ClinicalTrials.gov Identifier number: NCT00595816. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4702350</comments>
            <pubDate>Sun, 10 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4702350</guid>        </item>
        <item>
            <title>Would the field of cognitive neuroscience be advanced by sharing functional MRI data?</title>
            <link>http://www.medworm.com/index.php?rid=4691408&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F34</link>
            <description>During the past two decades, the advent of functional magnetic resonance imaging (fMRI) has fundamentally changed our understanding of brain-behavior relationships. However, the data from any one study add only incrementally to the big picture. This fact raises important questions about the dominant practice of performing studies in isolation. To what extent are the findings from any single study reproducible? Are researchers who lack the resources to conduct a fMRI study being needlessly excluded? Is pre-existing fMRI data being used effectively to train new students in the field? Here, we will argue that greater sharing and synthesis of raw fMRI data among researchers would make the answers to all of these questions more favorable to scientific discovery than they are today and that such...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4691408</comments>
            <pubDate>Thu, 07 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4691408</guid>        </item>
        <item>
            <title>Understanding the benefit of metformin use in cancer treatment</title>
            <link>http://www.medworm.com/index.php?rid=4681593&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F33</link>
            <description>Biguanides have been developed for the treatment of hyperglycemia and type 2 diabetes. Recently, metformin, the most widely prescribed biguanide, has emerged as a potential anticancer agent. Epidemiological, preclinical and clinical evidence supports the use of metformin as a cancer therapeutic. The ability of metformin to lower circulating insulin may be particularly important for the treatment of cancers known to be associated with hyperinsulinemia, such as those of the breast and colon. Moreover, metformin may exhibit direct inhibitory effects on cancer cells by inhibiting mammalian target of rapamycin (mTOR) signaling and protein synthesis. The evidence supporting a role for metformin in cancer therapy and its potential molecular mechanisms of action are discussed. (Source: BMC Medicin...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4681593</comments>
            <pubDate>Tue, 05 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4681593</guid>        </item>
        <item>
            <title>Interpreting systematic reviews: are we ready to make our own conclusions?: A cross-sectional study</title>
            <link>http://www.medworm.com/index.php?rid=4657290&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F30</link>
            <description>Conclusions:
The majority of our participants could not generate appropriate conclusions from SRs independently. Judicious direction from the authors' conclusions still appears crucial to guiding our health care practitioners in identifying appropriate messages from research. Authors, editors and reviewers should ensure that the conclusions of a paper accurately reflect the results. Similar studies should be conducted in other settings where awareness and application of EBM are different.Please see Commentary: http://www.biomedcentral.com/1741-7015/9/31/. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4657290</comments>
            <pubDate>Tue, 29 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4657290</guid>        </item>
        <item>
            <title>How can we improve the interpretation of systematic reviews?</title>
            <link>http://www.medworm.com/index.php?rid=4657289&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F31</link>
            <description>A study conducted by Lai and colleagues, published this week in BMC Medicine, suggests that more guidance might be required for interpreting systematic review (SR) results. In the study by Lai and colleagues, positive (or favorable) results were influential in changing participants' prior beliefs about the interventions presented in the systematic review. Other studies have examined the relationship between favorable systematic review results and the publication of systematic reviews. An international registry may decrease the number of unpublished systematic reviews and will hopefully decrease redundancy, increase transparency, and increase collaboration within the SR community. In addition, using guidance from the Preferred Items for Systematic Reviews and Meta-analyses (PRISMA: http://w...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4657289</comments>
            <pubDate>Tue, 29 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4657289</guid>        </item>
        <item>
            <title>Interprofessional simulated learning: short-term associations between simulation and interprofessional collaboration</title>
            <link>http://www.medworm.com/index.php?rid=4640250&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F29</link>
            <description>Conclusion:
Results from this study indicate that focusing interprofessional simulation education on shared leadership may provide the most leverage to improve interprofessional care. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4640250</comments>
            <pubDate>Sun, 27 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4640250</guid>        </item>
        <item>
            <title>Chronic fatigue syndrome in an ethnically diverse population: the influence of psychosocial adversity &amp; physical inactivity</title>
            <link>http://www.medworm.com/index.php?rid=4620464&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F26</link>
            <description>Conclusions:
The prevalence of CFS, but not chronic fatigue, varies by ethnic group. Anxiety, depression, physical inactivity, social strain, and negative aspects of social support together accounted for prevalence differences of CFS in the overall sample. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4620464</comments>
            <pubDate>Mon, 21 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4620464</guid>        </item>
        <item>
            <title>Regulation of vascular tone by adipocytes</title>
            <link>http://www.medworm.com/index.php?rid=4599142&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F25</link>
            <description>Recent studies have shown that adipose tissue is an active endocrine and paracrine organ secreting several mediators called adipokines. Adipokines include hormones, inflammatory cytokines and other proteins. In obesity, adipose tissue becomes dysfunctional, resulting in an overproduction of proinflammatory adipokines and a lower production of anti-inflammatory adipokines. The pathological accumulation of dysfunctional adipose tissue that characterizes obesity is a major risk factor for many other diseases, including type 2 diabetes, cardiovascular disease and hypertension. Multiple physiological roles have been assigned to adipokines, including the regulation of vascular tone. For example, the unidentified adipocyte-derived relaxing factor (ADRF) released from adipose tissue has been shown...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4599142</comments>
            <pubDate>Wed, 16 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4599142</guid>        </item>
        <item>
            <title>&quot;Gut health&quot; - a new objective in medicine?</title>
            <link>http://www.medworm.com/index.php?rid=4588959&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F24</link>
            <description>'Gut health' is a term increasingly used in the medical literature and by the food industry. It covers multiple positive aspects of the gastrointestinal (GI) tract, such as the effective digestion and absorption of food, the absence of GI illness, normal and stable intestinal microbiota, effective immune status and a state of well-being. From a scientific point of view, however, it is still extremely unclear exactly what gut health is, how it can be defined and how it can be measured. The GI barrier adjacent to the GI microbiota appears to be the key to understanding the complex mechanisms that maintain gut health. Any impairment of the GI barrier can increase the risk of developing infectious, inflammatory and functional GI diseases, as well as extraintestinal diseases such as immune-medi...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4588959</comments>
            <pubDate>Mon, 14 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4588959</guid>        </item>
        <item>
            <title>Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report</title>
            <link>http://www.medworm.com/index.php?rid=4558226&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F22</link>
            <description>Conclusions:
This pilot study is the first to report a significant relationship between the severity of CCSVI and hypoperfusion in the brain parenchyma. These preliminary findings should be confirmed in a larger cohort of MS patients to ensure that they generalize to the MS population as a whole. Reduced perfusion could contribute to the known mechanisms of virtual hypoxia in degenerated axons. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4558226</comments>
            <pubDate>Mon, 07 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4558226</guid>        </item>
        <item>
            <title>Analyses of cerebral microdialysis in patients with traumatic brain injury: relations to intracranial pressure, cerebral perfusion pressure and catheter placement</title>
            <link>http://www.medworm.com/index.php?rid=4539531&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F21</link>
            <description>Conclusions:
The multitude of highly perturbed local chemistry seen with MD in patients with TBI predominately represents long-term metabolic patterns and is weakly correlated to ICP and CPP. This suggests that disturbances other than pressure and/or flow have a dominant influence on MD levels in patients with TBI. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4539531</comments>
            <pubDate>Wed, 02 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4539531</guid>        </item>
        <item>
            <title>Significance testing as perverse probabilistic reasoning</title>
            <link>http://www.medworm.com/index.php?rid=4530698&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F20</link>
            <description>DiscussionThis paper provides an accessible treatment of the concepts needed to avoid misinterpreting significance tests. We begin by thoroughly explaining the basic concepts of probability theory, in particular providing an account of the origin and meaning of Bayes' rule, showing that its scope is more profound than generally appreciated. Next, we explain the two essential ingredients of significance testing, binary hypothesis testing and p-values. We then show that significance testing as usually understood represents a perversion of sound probabilistic reasoning. We show how understanding Bayes' rule can protect against common errors in statistical reasoning, and how physicians can exploit their experience with interpreting diagnostic tests to gain solid intuitions about probabilistic ...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4530698</comments>
            <pubDate>Mon, 28 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4530698</guid>        </item>
        <item>
            <title>MUC4 gene polymorphisms associate with endometriosis development and endometriosis-related infertility</title>
            <link>http://www.medworm.com/index.php?rid=4516072&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F19</link>
            <description>Conclusions:
MUC4 polymorphisms are associated with endometriosis development and endometriosis-related infertility in the Taiwanese population. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4516072</comments>
            <pubDate>Thu, 24 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4516072</guid>        </item>
        <item>
            <title>EEG complexity as a biomarker for autism spectrum disorder risk</title>
            <link>http://www.medworm.com/index.php?rid=4505932&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F18</link>
            <description>Conclusions:
This proof-of-principle study suggests that mMSE computed from resting state EEG signals may be a useful biomarker for early detection of risk for ASD and abnormalities in cognitive development in infants. To our knowledge, this is the first demonstration of an information theoretic analysis of EEG data for biomarkers in infants at risk for a complex neurodevelopmental disorder. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4505932</comments>
            <pubDate>Tue, 22 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4505932</guid>        </item>
        <item>
            <title>Comparison of postmenopausal endogenous sex hormones among Japanese, Japanese Brazilians, and non-Japanese Brazilians</title>
            <link>http://www.medworm.com/index.php?rid=4487936&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F16</link>
            <description>Conclusions:
We found higher levels of estrogens and androgens in Japanese Brazilians than in Japanese and levels similar to or higher than in non-Japanese Brazilians. Our findings may help explain the increase in the incidence and mortality rate of breast cancer among Japanese Brazilians. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4487936</comments>
            <pubDate>Wed, 16 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4487936</guid>        </item>
        <item>
            <title>The 'three Ps' of cancer survivorship care</title>
            <link>http://www.medworm.com/index.php?rid=4458649&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F14</link>
            <description>No abstract (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4458649</comments>
            <pubDate>Thu, 10 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4458649</guid>        </item>
        <item>
            <title>Evidence for somatic gene conversion and deletion in bipolar disorder, Crohn's disease, coronary artery disease, hypertension, rheumatoid arthritis, type-1 diabetes, and type-2
diabetes</title>
            <link>http://www.medworm.com/index.php?rid=4539532&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F12</link>
            <description>Conclusions:
The associations derived represent the first evidence that somatic gene conversion could be a significant causative factor in each of the seven diseases. The specific genes provide potential insights about disease mechanisms, and are strong candidates for further study. Please see Commentary: http://www.biomedcentral.com/1741-7015/9/13/abstract. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4539532</comments>
            <pubDate>Thu, 03 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4539532</guid>        </item>
        <item>
            <title>Evidence for somatic gene conversion and deletion in bipo-
lar disorder, Crohn's disease, coronary artery disease, hyper-
tension, rheumatoid arthritis, type-1 diabetes, and type-2
diabetes</title>
            <link>http://www.medworm.com/index.php?rid=4432050&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F12</link>
            <description>Conclusions:
The associations derived represent the first evidence that somatic gene conversion could be a significant causative factor in each of the seven diseases. The specific genes provide potential insights about disease mechanisms, and are strong candidates for further study. Please see Commentary:http://www.biomedcentral.com/1741-7015/9/13/abstract. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4432050</comments>
            <pubDate>Thu, 03 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4432050</guid>        </item>
        <item>
            <title>Another tool in the genome-wide association study arsenal: population-based detection of somatic gene conversion</title>
            <link>http://www.medworm.com/index.php?rid=4432049&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F13</link>
            <description>The hunt for the genetic contributors to complex disease has used a number of strategies, resulting in the identification of variants associated with many of the common diseases affecting society. However most of the genetic variants detected to date are single nucleotide polymorphisms (SNPs) and copy number variants (CNVs) and fall far short of explaining the full genetic component of any given disease. An as yet untapped genomic mechanism is somatic gene conversion and deletion, which could be complicit in disease risk but has been challenging to detect in genome-wide datasets. In a recent publication in BMC Medicine by Kenneth Ross, the author uses existing datasets to look at somatic gene conversion and deletion in human disease. Here, we describe how Ross's recent efforts to detect su...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4432049</comments>
            <pubDate>Thu, 03 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4432049</guid>        </item>
        <item>
            <title>Advances in understanding ischemic acute kidney injury</title>
            <link>http://www.medworm.com/index.php?rid=4427829&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F11</link>
            <description>Acute kidney injury (AKI) is independently associated with increased morbidity and mortality.Ischemia is the leading cause of AKI, and short of supportive measures, no currently available therapy can effectively treat or prevent ischemic AKI. This paper discusses recent developments in the understanding of ischemic AKI pathophysiology, the emerging relationship between ischemic AKI and development of progressive chronic kidney disease, and promising novel therapies currently under investigation. On the basis of recent breakthroughs in understanding the pathophysiology of ischemic AKI, therapies that can treat or even prevent ischemic AKI may become a reality in the near future. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4427829</comments>
            <pubDate>Wed, 02 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4427829</guid>        </item>
        <item>
            <title>A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: A Hellenic Cooperative Oncology Group study</title>
            <link>http://www.medworm.com/index.php?rid=4417815&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F10</link>
            <description>Conclusions:
Irinotecan added to weekly bolus 5FU plus LV did not result in improvement in disease-free or overall survival in stage II or III colon cancer, but did increase toxicity.Trial registration: Australian New Zealand Clinical Trials Registry: ACTRN12610000148077 (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4417815</comments>
            <pubDate>Mon, 31 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4417815</guid>        </item>
        <item>
            <title>Synopsis and meta-analysis of genetic association studies in osteoporosis for the focal adhesion family genes: the CUMAGAS-OSTEOporosis information system</title>
            <link>http://www.medworm.com/index.php?rid=4398124&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F9</link>
            <description>Background:
Focal adhesion (FA) family genes have been studied as candidate genes for osteoporosis, but the results of genetic association studies (GASs) are controversial. To clarify these data, a systematic assessment of GASs for FA genes in osteoporosis was conducted.
Methods:
We developed Cumulative Meta-Analysis of GAS-OSTEOporosis (CUMAGAS-OSTEOporosis), a web-based information system that allows the retrieval, analysis and meta-analysis (for allele contrast, recessive, dominant, additive and codominant models) of data from GASs on osteoporosis with the capability of update. GASs were identified by searching the PubMed and HuGE PubLit databases.
Results:
Data from 72 studies involving 13 variants of 6 genes were analyzed and catalogued in CUMAGAS-OSTEOporosis. Twenty-two studies prod...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4398124</comments>
            <pubDate>Wed, 26 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4398124</guid>        </item>
        <item>
            <title>Treatment of myofascial trigger points in patients with chronic shoulder pain: a randomized, controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=4392962&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F8</link>
            <description>Conclusions:
The results of this study show that 12-week comprehensive treatment of MTrPs in shoulder muscles reduces the number of muscles with active MTrPs and is effective in reducing symptoms and improving shoulder function in patients with chronic shoulder pain.Trial Registration. Current Controlled Trials [ISRCTN75722066]. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4392962</comments>
            <pubDate>Mon, 24 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4392962</guid>        </item>
        <item>
            <title>Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review</title>
            <link>http://www.medworm.com/index.php?rid=4359571&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F7</link>
            <description>Conclusions:
The accuracy of COPD epidemiological parameters is important for guiding decision making with regard to preventive measures, interventions and patient management in various health care systems. Therefore, the recent initiatives for standardizing data collection should be enhanced to result in COPD epidemiological estimates of improved quality. Moreover, establishing international guidelines for reporting research on COPD may also constitute a major contribution. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4359571</comments>
            <pubDate>Tue, 18 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4359571</guid>        </item>
        <item>
            <title>Expenditures for the care of HIV-infected patients in rural areas in China's antiretroviral therapy programs</title>
            <link>http://www.medworm.com/index.php?rid=4359572&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F6</link>
            <description>Background:
The Chinese government has provided health services to those infected by the human immunodeficiency virus (HIV) under the acquired immunodeficiency syndrome (AIDS) care policy since 2003. Detailed research on the actual expenditures and costs for providing care to patients with AIDS is needed for future financial planning of AIDS health care services and possible reform of HIV/AIDS-related policy. The purpose of the current study was to determine the actual expenditures and factors influencing costs for untreated AIDS patients in a rural area of China after initiating highly active antiretroviral therapy (HAART) under the national Free Care Program (China CARES).
Methods:
A retrospective cohort study was conducted in Yunnan and Shanxi Provinces, where HAART and all medical care...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4359572</comments>
            <pubDate>Mon, 17 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4359572</guid>        </item>
        <item>
            <title>Perceived morbidity and community burden after a Chikungunya outbreak: the TELECHIK survey, a population-based cohort study</title>
            <link>http://www.medworm.com/index.php?rid=4348491&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F5</link>
            <description>Background:
Persistent disabilities are key manifestations of Chikungunya virus (CHIKV) infection, especially incapacitating polyarthralgia and fatigue. So far, little is known about their impact on health status. The present study aimed at describing the burden of CHIKV prolonged or late-onset symptoms on the self-perceived health of La Reunion islanders.
Methods:
At 18 months after an outbreak of Chikungunya virus, we implemented the TELECHIK survey; a retrospective cohort study conducted on a random sample of the representative SEROCHIK population-based survey. A total of 1,094 subjects sampled for CHIKV-specific IgG antibodies in the setting of La Reunion island in the Indian Ocean, between August 2006 and October 2006, were interviewed about current symptoms divided into musculoskelet...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4348491</comments>
            <pubDate>Fri, 14 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4348491</guid>        </item>
        <item>
            <title>Blood lipid profiles and peripheral blood mononuclear cell cholesterol metabolism gene expression in patients with and without methotrexate treatment</title>
            <link>http://www.medworm.com/index.php?rid=4341672&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F4</link>
            <description>Background:
Methotrexate (MTX) is the most commonly prescribed disease-modifying antirheumatic drug (DMARD) in rheumatoid arthritis. ATP-binding cassette transporter-A1 (ABCA1) and 27-Hydroxylase (HY27) are known antiatherogenic proteins that promote cellular cholesterol efflux. In THP-1 macrophages, MTX can promote the reversal of cholesterol transport, limit foam cell formation and also reverse COX-2 inhibitor-mediated downregulation of ABCA1. Despite its antiatherogenic potential in vitro, the impact of clinical use of low-dose MTX on cholesterol metabolism in humans is unknown. Objective of the study was to examine whether clinical MTX use is associated with altered blood lipids and/or ABCA1/HY27 expressions.
Methods:
In all, 100 rheumatoid arthritis subjects were recruited from a medi...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4341672</comments>
            <pubDate>Thu, 13 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4341672</guid>        </item>
        <item>
            <title>Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy</title>
            <link>http://www.medworm.com/index.php?rid=4335940&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F3</link>
            <description>Conclusion:
Following a structured therapy plan based on a &quot;test and treat&quot; strategy, the prevalence of clopidogrel or aspirin low response can be significantly reduced and the risk of inadequate dual antiplatelet therapy minimized.Trial Registration: NCT01212302 (Clinicaltrials.gov) (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4335940</comments>
            <pubDate>Wed, 12 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4335940</guid>        </item>
        <item>
            <title>Differential endothelial cell gene expression by African Americans versus Caucasian Americans: a possible contribution to health disparity in vascular disease and cancer</title>
            <link>http://www.medworm.com/index.php?rid=4335941&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F2</link>
            <description>This study addresses the possibility that genetic differences affecting the biology of the vascular endothelium could be a factor contributing to the increased burden of cardiovascular disease and cancer among African Americans (AA) compared to Caucasian Americans (CA).
Methods:
From self-identified, healthy, 20 to 29-year-old AA (n = 21) and CA (n = 17), we established cultures of blood outgrowth endothelial cells (BOEC) and applied microarray profiling. BOEC have never been exposed to in vivo influences, and their gene expression reflects culture conditions (meticulously controlled) and donor genetics. Significance Analysis of Microarray identified differential expression of single genes. Gene Set Enrichment Analysis examined expression of pre-determined gene sets that survey nine biolog...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4335941</comments>
            <pubDate>Tue, 11 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4335941</guid>        </item>
        <item>
            <title>Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study</title>
            <link>http://www.medworm.com/index.php?rid=4329709&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F9%2F1</link>
            <description>Conclusions:
People admitted to hospital with immune-mediated diseases may be at an increased risk of subsequent VTE. Our findings need independent confirmation or refutation; but, if confirmed, there may be a role for thromboprophylaxis in some patients with these diseases. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4329709</comments>
            <pubDate>Mon, 10 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4329709</guid>        </item>
        <item>
            <title>Diagnosis and biomarkers of predementia in Alzheimer's disease</title>
            <link>http://www.medworm.com/index.php?rid=4280112&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F8%2F89</link>
            <description>In view of the growing prevalence of Alzheimer's disease (AD) worldwide, there is an urgent need for the development of better diagnostic tools and more effective therapeutic interventions. At the earliest stages of AD, no significant cognitive or functional impairment is detected by conventional clinical methods. However, new technologies based on structural and functional neuroimaging, and on the biochemical analysis of cerebrospinal fluid (CSF) may reveal correlates of intracerebral pathology in individuals with mild, predementia symptoms. These putative correlates are commonly referred to as AD-related biomarkers. The relevance of the early diagnosis of AD relies on the hypothesis that pharmacological interventions with disease-modifying compounds are likely to produce clinically relev...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4280112</comments>
            <pubDate>Wed, 22 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4280112</guid>        </item>
        <item>
            <title>Obesity related methylation changes in DNA of peripheral blood leukocytes</title>
            <link>http://www.medworm.com/index.php?rid=4276917&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F8%2F87</link>
            <description>Conclusions:
Our results provide evidence that obesity is associated with methylation changes in blood leukocyte DNA. Further studies are warranted to determine the causal direction of this relationship as well as whether such methylation changes can lead to immune dysfunction.See commentary: http://www.biomedcentral.com/1741-7015/8/XX/abstract (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4276917</comments>
            <pubDate>Tue, 21 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4276917</guid>        </item>
        <item>
            <title>Epigenetics and obesity: the devil is in the details</title>
            <link>http://www.medworm.com/index.php?rid=4276916&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F8%2F88</link>
            <description>Obesity is a complex disease with multiple well-defined risk factors. Nevertheless, susceptibility to obesity and its sequelae within obesogenic environments varies greatly from one person to the next, suggesting a role for gene x environment interactions in the etiology of the disorder. Epigenetic regulation of the human genome provides a putative mechanism by which specific environmental exposures convey risk for obesity and other human diseases and is one possible mechanism that underlies the gene x environment-treatment interactions observed in epidemiological studies and clinical trials. A study published in BMC Medicine this month by Wang et al. reports on an examination of DNA methylation in peripheral blood leukocytes of lean and obese adolescents, comparing methylation patterns be...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4276916</comments>
            <pubDate>Tue, 21 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4276916</guid>        </item>
        <item>
            <title>Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients</title>
            <link>http://www.medworm.com/index.php?rid=4274380&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F8%2F86</link>
            <description>Conclusions:
This study shows that endoglin is an indicator of hypertension- and diabetes-associated vascular pathologies as endothelial dysfunction and cardiovascular damage. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4274380</comments>
            <pubDate>Mon, 20 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4274380</guid>        </item>
        <item>
            <title>Clinically significant changes in burden and depression among dementia caregivers following nursing home admission</title>
            <link>http://www.medworm.com/index.php?rid=4270617&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F8%2F85</link>
            <description>The objectives of this study were to determine whether clinically significant changes in symptoms of burden and depression occur among caregivers within 12 months of nursing home admission (NHA) of their relatives with dementia, and to identify key predictors of clinically persistent burden and depression in the first year after institutionalization.
Methods:
Secondary longitudinal analysis of dementia caregivers were recruited from eight catchment areas in the United States with 6- and 12-month post-placement follow-up data. The sample included data on 1,610 dementia caregivers with pre- and six-month post-placement data and 1,116 with pre-placement, six-month, and 12-month post-placement data. Burden was measured with a modified version of the Zarit Burden Inventory. Depressive symptoms ...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4270617</comments>
            <pubDate>Fri, 17 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4270617</guid>        </item>
        <item>
            <title>Systematic review of the evidence relating FEV1 decline to giving up smoking</title>
            <link>http://www.medworm.com/index.php?rid=4257188&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F8%2F84</link>
            <description>Conclusion:
The available data have numerous limitations, but clearly show that continuing smokers have a beta that is dose-related and over 10 mL/yr greater than in never smokers, ex-smokers or quitters. The greater decline in those with respiratory disease or reduced lung function is consistent with some smokers having a more rapid rate of FEV1 decline. These results help in designing studies comparing continuing smokers of conventional cigarettes and switchers to novel products. (Source: BMC Medicine)</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4257188</comments>
            <pubDate>Tue, 14 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4257188</guid>        </item>
        <item>
            <title>Advances in the field of nanooncology</title>
            <link>http://www.medworm.com/index.php?rid=4257189&amp;cid=s_28859_49_f&amp;fid=28859&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1741-7015%2F8%2F83</link>
            <description>Nanooncology, the application of nanobiotechnology to the management of cancer, is currently the most important chapter of nanomedicine. Nanobiotechnology has refined and extended the limits of molecular diagnosis of cancer, for example, through the use of gold nanoparticles and quantum dots. Nanobiotechnology has also improved the discovery of cancer biomarkers, one such example being the sensitive detection of multiple protein biomarkers by nanobiosensors. Magnetic nanoparticles can capture circulating tumor cells in the bloodstream followed by rapid photoacoustic detection. Nanoparticles enable targeted drug delivery in cancer that increases efficacy and decreases adverse effects through reducing the dosage of anticancer drugs administered. Nanoparticulate anticancer drugs can cross som...</description>
            <author>BMC Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4257189</comments>
            <pubDate>Mon, 13 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4257189</guid>        </item>
    </channel>
</rss>

